Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page Not Available ()Premium Content

Exelixis Inc (EXEL)

2015-02-26@16:05:00 ET
Exelixis to Present at the Cowen and Company 35th Annual Health Care Conference on Tuesday, March 3 (BIZ)

2015-02-26@12:52:38 ET
Exelixis Announces Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update (ABW)

2015-02-26@06:55:39 ET
Metastatic Renal Cell Carcinoma Therapeutics Pipeline Review 2015 - 34 Companies & 38 Drug Profiles (MTO)

2015-02-25@21:07:02 ET
Exelixis, Inc.Corporate Event Announcement Notice (WSH)

2015-02-25@09:02:24 ET
Follicular Thyroid Cancer - Pipeline Review, H1 2015 (MTO)

2015-02-24@22:08:13 ET
Exelixis, Inc.Corporate Event Announcement Notice (WSH)

2015-02-24@21:37:37 ET
Exelixis, Inc.Corporate Event Announcement Notice (WSH)

2015-02-24@21:08:59 ET
Exelixis, Inc.Corporate Event Announcement Notice (WSH)

2015-02-24@16:57:06 ET
8-K: EXELIXIS, INC. (EDK)

2015-02-24@16:06:01 ET
Exelixis Announces Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update (BIZ)

2015-02-24@11:21:38 ET
Brain Cancer Therapeutics Pipeline Review, H1 2015 - Analysis of 37 Companies & 60 Drug Profiles (MTO)

2015-02-24@10:29:43 ET
Peritoneal Cancer - Pipeline Review, H1 2015 - 59 Companies & 83 Drug Profiles (MTO)

2015-02-24@05:06:18 ET
Exelixis's NDA for metastatic melanoma drug receives FDA acceptance (DTM)

2015-02-20@08:10:00 ET
Recent Developments at Biotechnology Companies: Special Research on Exelixis,ICON, Incyte, Luna Innovations, and Oncothyreon (PRN)

2015-02-19@13:05:04 ET
Stock to Watch: Exelixis Up 5.3% (EXEL) (F77)

2015-02-19@12:33:39 ET
Traders Get Bullish on Shares of Exelixis, Shares Up 5.3% (EXEL) (PSM)

2015-02-19@01:00:03 ET
Exelixis Announces Acceptance of New Drug Application for Cobimetinib in Combination with Vemurafenib for Treatment of Patients with BRAF V600 Mutation-Positive Advanced Melanoma (BIZ)

2015-02-17@09:10:00 ET
Technical Briefing on Biotech Stocks -- Exelixis, Exact Sciences, Idera Pharma, Seattle Genetics, and Ironwood Pharma (PRN)

2015-02-13@13:38:54 ET
Exelixis Up 7.9%, Shares Break Through Resistance (EXEL) (PSM)